Moderna and Merck have reported promising results for their personalised mRNA cancer vaccine, Intismeran, which reduced melanoma recurrence and spread in late-stage trials. The interim
Forcible military recruitment in Ukraine has escalated into violence, with incidents of “busification” reported, where men are ambushed on the street and taken to mobilisation